WuXi Biologics: Spotlight On Property Disposal And Operating Metrics (Rating Upgrade)
Source: SeekingAlpha
2025-01-21 17:18:58 ET
Summary
- My rating upgrade for WuXi Biologics to a Buy has taken into consideration its latest corporate move and business disclosures.
- The sale of its European manufacturing facility will throw up margin improvement and capital allocation opportunities for WXXWY.
- The company has secured new projects and new customers from markets outside its home market despite geopolitical concerns.
I have deci ded to change WuXi Biologics' ( WXXWY ) ( WXIBF ) [2269:HK] rating from a Hold to a Buy. My prior September 27, 2024 update previewed the company's 2024 earnings and looked at the potential new law affecting its future performance. I am turning positive on WXXWY after analyzing its latest actions and disclosures....
Read the full article on Seeking Alpha
For further details see:
WuXi Biologics: Spotlight On Property Disposal And Operating Metrics (Rating Upgrade)
Wuxi Biologics Cayman Inc
NASDAQ: WXIBF
WXIBF Trading
0.0% G/L:
$4.60 Last:
5,000 Volume:
$4.60 Open:
